Patents by Inventor Phillip John Sharp

Phillip John Sharp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of protease inhibitors for treating skin wounds
    Patent number: 6344189
    Abstract: The healing of chronic wounds, such as leg ulcers, is accelerated via topical administration of a serine protease inhibitor, such as PAI-2. Wound healing also is promoted using combinations of protease inhibitors, such as PAI-2 with other serine protease inhibitors and/or with protease inhibitors such inhibitors of metalloproteinases, acid proteases, and thiol proteases, respectively.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: February 5, 2002
    Assignee: Biotech Australia Pty., Ltd.
    Inventors: Clive Leighton Bunn, John Lewis Andrews, Phillip John Sharp
  • Protease inhibitors for use in the treatment of psoriasis
    Patent number: 6288025
    Abstract: Psoriasis may be treated by topical administration of a urokinase inhibitor, such as PAI-2, or a combination of protease inhibitors, such as PAI-2 with other serine protease inhibitors and/or with protease inhibitors such as inhibitors of metalloproteinases, acid proteases, and thiol proteases.
    Type: Grant
    Filed: August 5, 1999
    Date of Patent: September 11, 2001
    Assignee: Biotech Australia Pty Limited
    Inventors: Clive Leighton Bunn, Phillip John Sharp
  • Nematode vaccine
    Patent number: 5942413
    Abstract: Disclosed is a substantially purified antigen derived from a first species of parasitic nematodes, which antigen is capable of providing protection to a host from parasitism infestation by a second nematode species, which may be the same as or different from the first nematode species, following vaccination of the host with the antigen, characterized in that the antigen is proteinaceous, has a pI between 3.8 and 4.4, can be bound by lentil lectin and Helix promatia and has a molecular weight of approximately 45 kD as determined by SDS-PAGE.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: August 24, 1999
    Assignees: Biotech Australia PTY Limited, Commonwealth Scientific and Industrial Research Organization
    Inventors: Phillip John Sharp, Barry Maxwell Wagland, Gary Stewart Cobon
  • Nematode vaccine
    Patent number: 5871738
    Abstract: Disclosed is a substantially purified antigen derived from a first parasitic nematode species which, when administered to a host animal, is capable of protecting the host animal from infestation by a second parasitic nematode species, wherein the first and second parasitic nematode species may be the same or different, and the antigen has an apparent molecular weight of 40 kD as determined by SDS-PAGE under reducing conditions.
    Type: Grant
    Filed: October 6, 1992
    Date of Patent: February 16, 1999
    Assignees: Biotech Australia Pty. Limited, Commonwealth Scientific and Industrial Research Organization
    Inventors: Phillip John Sharp, Barry Maxwell Wagland
  • Nematode vaccine
    Patent number: 5734035
    Abstract: Disclosed is a substantially purified antigen derived from a first parasitic nematode species which, when administered to a host animal, is capable of protecting the host animal from infestation by a second parasitic mematode species, wherein the first and second parasitic nematode species may be the same or different, and the antigen has an apparent molecular weight of 40 kD as determined by SDS-PAGE under reducing conditions.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 31, 1998
    Assignees: Biotech Australia Pty Limited, Commonwealth Scientific and Industrial Research Organisation
    Inventors: Phillip John Sharp, Barry Maxwell Wagland